Evaluation of new renal (kidney) biomarkers for kidney damage in normal dogs and dogs receiving nephrotoxic drugs.

Study details:

Species: Dogs

Tumor: Kidney disease

Purpose of Study: Inclusion Criteria and General Background Information: Dogs receiving kidney toxic drugs (e.g., tyrosine kinase inhibitors): must be at least 2 years old, must weigh at least 22 lbs, must have no previous history of kidney disease or protein in the urine, must have a life expectancy of at least 4 months. Dogs receiving Kidney toxic drugs (e.g., tyrosine kinase inhibitors) will participate for up to 6 months with a pretreatment blood and urine sample, and additional samples two weeks after initiation of therapy and then monthly thereafter. For more information, click here